[Form 3] Nano-X Imaging Ltd. Initial Statement of Beneficial Ownership

Nano-X Imaging Ltd. Chief Legal Officer Marina Gofman Feler filed an initial ownership report on 2026-03-18.

Rhea-AI Filing Summary

Nano-X Imaging Ltd. Chief Legal Officer Marina Gofman Feler filed an initial ownership report on 2026-03-18. She holds stock options over 15,000 ordinary shares at an exercise price of 17.6300 expiring on 2032-11-07, options over 10,000 shares at 17.6300 expiring on 2033-04-28, and options over 30,000 shares at 11.5200 expiring on 2033-05-23.

She also holds 20,000 ordinary shares underlying restricted share units granted on 2026-02-05, which vest 50% on the 12-month anniversary of the grant date and 50% on the 24-month anniversary. A separate line shows 26,316 additional ordinary shares held directly.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Gofman Feler Marina

Role Chief Legal Officer

Type	Security	Shares	Price	Value
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Ordinary shares	--	--	--
holding	Ordinary shares	--	--	--

Holdings After Transaction: Stock Option (right to buy ordinary shares) — 55,000 contracts (Direct); Ordinary shares — 46,316 shares (Direct)

Footnotes (4)

1. F1. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on February 5, 2026 and of which 50% will vest on the 12-month anniversary of the grant date and the remaining 50% will vest upon the 24-month anniversary of the grant date.
2. F2. The options reported in this row were granted to the Reporting Person by the Issuer on November 7, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that grant date (November 7, 2026).
3. F3. The options reported in this row were granted to the Reporting Person by the Issuer on April 28, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that grant date (April 28, 2027).
4. F4. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that appointment date (May 23, 2027).

FAQ

What does the Nano-X Imaging (NNOX) Form 3 filing show for Marina Gofman Feler?

The Form 3 shows Marina Gofman Feler’s initial ownership as Chief Legal Officer, including stock options over 55,000 ordinary shares and direct holdings of ordinary shares and restricted share units with defined vesting and expiration schedules.

How many Nano-X Imaging (NNOX) stock options does the CLO hold and at what prices?

She holds options linked to 15,000 and 10,000 ordinary shares at an exercise price of $17.6300, and options linked to 30,000 ordinary shares at $11.5200, each with separate expiration dates in 2032 and 2033.

When do Marina Gofman Feler’s Nano-X Imaging (NNOX) stock options expire?

The options expire on 2032-11-07 for 15,000 underlying shares, 2033-04-28 for 10,000 underlying shares, and 2033-05-23 for 30,000 underlying shares, assuming they vest and are not exercised earlier.

What are the vesting terms of the Nano-X Imaging (NNOX) restricted share units reported?

The filing states 20,000 ordinary shares underlying restricted share units granted on 2026-02-05, with 50% vesting on the 12-month anniversary of the grant date and the remaining 50% vesting on the 24-month anniversary.

How many Nano-X Imaging (NNOX) ordinary shares does the CLO hold directly?

One row shows 20,000 ordinary shares underlying restricted share units, while another row lists 26,316 ordinary shares. Both positions are reported as directly owned, reflecting a mix of unvested units and already issued shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 11:29 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gofman Feler Marina

(Last) (First) (Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA 4970602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	20,000	D
Ordinary shares(1)	26,316	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)	(2)	11/07/2032	Ordinary shares	15,000	$17.63	D
Stock Option (right to buy ordinary shares)	(3)	04/28/2033	Ordinary shares	10,000	$17.63	D
Stock Option (right to buy ordinary shares)	(4)	05/23/2033	Ordinary shares	30,000	$11.52	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on February 5, 2026 and of which 50% will vest on the 12-month anniversary of the grant date and the remaining 50% will vest upon the 24-month anniversary of the grant date.

2. The options reported in this row were granted to the Reporting Person by the Issuer on November 7, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that grant date (November 7, 2026).

3. The options reported in this row were granted to the Reporting Person by the Issuer on April 28, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that grant date (April 28, 2027).

4. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that appointment date (May 23, 2027).

	/s/ Marina Gofman Feler	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)